Tyme Technologies, Inc. (TYME): Price and Financial Metrics
TYME Stock Price Chart More Charts
TYME Price/Volume Stats
Tyme Technologies, Inc. (TYME) Company Bio
Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology indications. It is developing SM-88, a combination therapy in Phase II development for prostate cancer. The company was founded in 2011 and is based in New York, New York.